Further Information
GZMA, granzyme A, Hanukah factor serine protease), Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3, CTL tryptase, HFSP, CTLA3, granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3), GZMA
WB: 1:500 - 1:2000
IF: 1:50 - 1:200
Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here is a T cell- and natural killer cell-specific serine protease that may function as a common component necessary for lysis of target cells by cytotoxic T lymphocytes and natural killer cells.
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Recombinant fusion protein containing a sequence corresponding to amino acids 29-262 of human GZMA (NP_006135.1).
3001
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
GZMA
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Observed: 35kDa
Affinity purification
Apoptosis, Cell Cycle, Immunology, Innate Immunity
P12544
Optimal dilutions for each application to be determined by the researcher.
